Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 29
Filtrar
Más filtros

Banco de datos
País/Región como asunto
Tipo del documento
Intervalo de año de publicación
1.
BMC Neurol ; 20(1): 152, 2020 Apr 23.
Artículo en Inglés | MEDLINE | ID: mdl-32326894

RESUMEN

BACKGROUND: Heart rate variability (HRV) decreases in Parkinson's disease (PD) and it can be considered a marker for cardiovascular dysautonomia. The purpose of this pilot study is to evaluate long-term time-domain analysis of HRV of PD patients and compare the results with those of matched healthy individuals. METHODS: Idiopathic PD patients without comorbidity impairing HRV, and age-matched healthy individuals were recruited in a pilot study. A long-term time domain analysis of HRV using 24-h ambulatory ECG was performed. RESULTS: Overall, 18 PD patients fulfilling inclusion criteria completed the evaluation (mean age was 55.6 ± 8.8, disease duration: 5.0 ± 4.7). Mean SCOPA-AUT score was 10.1 ± 7.3. Patients were on Hoehn & Yahr stage 1-2 and mean Levodopa Equivalent Dose (LED) was 311 ± 239.9. Mean of the 5-min standard deviation (SD) of R-R intervals distribution (SDNN) for all 5 min segments of the entire recording (ISDNN) was significantly lower in patients compared to controls. ISDNN was significantly different between Parkinson's disease patients and healthy controls. CONCLUSIONS: In our population characterized by mild to moderate disease severity, time-domain assessment of HRV seemed to be a potential tool to characterize cardiovascular dysautonomia. Decrease of ISDNN in PD may reflect an autonomic derangement extending all day and night long.


Asunto(s)
Enfermedades Cardiovasculares , Frecuencia Cardíaca/fisiología , Enfermedad de Parkinson , Anciano , Antiparkinsonianos/uso terapéutico , Enfermedades Cardiovasculares/diagnóstico , Enfermedades Cardiovasculares/etiología , Enfermedades Cardiovasculares/fisiopatología , Ritmo Circadiano/fisiología , Humanos , Levodopa/uso terapéutico , Persona de Mediana Edad , Enfermedad de Parkinson/complicaciones , Enfermedad de Parkinson/tratamiento farmacológico , Enfermedad de Parkinson/fisiopatología , Proyectos Piloto , Disautonomías Primarias/diagnóstico , Disautonomías Primarias/etiología , Disautonomías Primarias/fisiopatología
2.
Mol Psychiatry ; 20(8): 959-73, 2015 Aug.
Artículo en Inglés | MEDLINE | ID: mdl-25266126

RESUMEN

Neuregulin 1 (NRG1) is a trophic factor that has an essential role in the nervous system by modulating neurodevelopment, neurotransmission and synaptic plasticity. Despite the evidence that NRG1 and its receptors, ErbB tyrosine kinases, are expressed in mesencephalic dopaminergic nuclei and their functional alterations are reported in schizophrenia and Parkinson's disease, the role of NRG1/ErbB signalling in dopaminergic neurons remains unclear. Here we found that NRG1 selectively increases the metabotropic glutamate receptor 1 (mGluR1)-activated currents by inducing synthesis and trafficking to membrane of functional receptors and stimulates phosphatidylinositol 3-kinase-Akt-mammalian target of rapamycin (PI3K-Akt-mTOR) pathway, which is required for mGluR1 function. Notably, an endogenous NRG1/ErbB tone is necessary to maintain mGluR1 function, by preserving its surface membrane expression in dopaminergic neurons. Consequently, it enables striatal mGluR1-induced dopamine outflow in in vivo conditions. Our results identify a novel role of NRG1 in the dopaminergic neurons, whose functional alteration might contribute to devastating diseases, such as schizophrenia and Parkinson's disease.


Asunto(s)
Neuronas Dopaminérgicas/fisiología , Mesencéfalo/fisiología , Neurregulina-1/metabolismo , Receptores de Glutamato Metabotrópico/metabolismo , Animales , Dopamina/metabolismo , Neuronas Dopaminérgicas/efectos de los fármacos , Receptores ErbB/metabolismo , Masculino , Potenciales de la Membrana/efectos de los fármacos , Potenciales de la Membrana/fisiología , Mesencéfalo/efectos de los fármacos , Microdiálisis , Técnicas de Placa-Clamp , Fosfatidilinositol 3-Quinasas/metabolismo , Proteínas Proto-Oncogénicas c-akt/metabolismo , Ratas Wistar , Transducción de Señal/efectos de los fármacos , Serina-Treonina Quinasas TOR/metabolismo , Técnicas de Cultivo de Tejidos
3.
Curr Pain Headache Rep ; 20(3): 19, 2016 Mar.
Artículo en Inglés | MEDLINE | ID: mdl-26879877

RESUMEN

The Red Ear syndrome (RES) is an intriguing syndrome originally described for the first time nearly 20 years ago. RES is characterized by unilateral/bilateral episodes of pain and burning sensation of the ear, associated with ipsilateral erythema. RES episodes are indeed isolated in some patients, but they can occur in association with primary headaches, including in particular migraine in the developmental age. Although the underlying pathophysiological mechanisms are still uncertain, in the recent years the described comorbidities have aroused increasing interest because of possible clinical implications. Moreover, RES seems to be more often associated with clinical features of migraine partially provoked by the involvement of the parasympathetic system. This clinical association has shed new light on the pathophysiology of RES, supporting the hypothesis of a shared pathophysiological background, for example, through the activation of the trigeminal autonomic reflex. Current therapies of RES will be also discussed. Finally, we will resume the more controversial aspects of this relatively new and probably underestimated neurological syndrome.


Asunto(s)
Enfermedades del Oído/fisiopatología , Eritema/fisiopatología , Cefalea/fisiopatología , Trastornos Migrañosos/fisiopatología , Dolor/fisiopatología , Analgésicos no Narcóticos , Comorbilidad , Enfermedades del Oído/diagnóstico , Enfermedades del Oído/etiología , Eritema/diagnóstico , Eritema/etiología , Antagonistas de Aminoácidos Excitadores/uso terapéutico , Cefalea/complicaciones , Humanos , Trastornos Migrañosos/complicaciones , Dolor/tratamiento farmacológico , Dolor/etiología , Guías de Práctica Clínica como Asunto , Prevalencia , Síndrome
4.
Eur J Ageing ; 21(1): 14, 2024 Apr 24.
Artículo en Inglés | MEDLINE | ID: mdl-38656628

RESUMEN

People constantly process temporal, numerical, and length information in everyday activities and interactions with the environment. However, it is unclear whether quantity perception changes during ageing. Previous studies have provided heterogeneous results, sometimes showing an age-related effect on a particular quantity, and other times reporting no differences between young and elderly samples. However, three dimensions were never compared within the same study. Here, we conducted two experiments with the aim of investigating the processing of duration, numerosity and length in both healthy and pathological ageing. The experimental paradigm consisted of three bisection tasks in which participants were asked to judge whether the presented stimulus (i.e. a time interval, a group of dots, or a line) was more similar to the short/few or long/many standards. The first study recruited healthy young and elderly participants, while the second recruited healthy elderly participants and patients with Parkinson's disease, a clinical condition commonly associated with temporal impairments. The results of both experiments showed that discrimination precision differed between domains in all groups, with higher precision in the numerosity task and lower sensitivity in judging duration. Furthermore, while discrimination abilities were affected in healthy elderly and, even more so, in Parkinson's disease group, no domain-specific impairments emerged. According to our research, reduced discrimination precision might be explained by an alteration of a single system for all quantities or by an age-related general cognitive decline.

5.
J Biol Regul Homeost Agents ; 27(2 Suppl): 1-9, 2013.
Artículo en Inglés | MEDLINE | ID: mdl-24813311

RESUMEN

Mitochondria play a pivotal role in a number of biochemical processes in the neuron including energy metabolism and ATP production, intracellular Ca2+ homeostasis and cell signalling which are all implicated in the regulation of neuronal excitability. For this reason, it is not surprising that alterations in mitochondrial function have emerged as a hallmark of aging and various age-related neurodegenerative diseases in which a progressive functional decline of mitochondria has been described. The evidence that mitochondria are concentrated in synapses, together with the observation that synaptic dysfunction identifies an early forerunner of a later neurodegeneration, strongly suggests that significant alterations to synaptic mitochondrial localization, number, morphology, or function can be detrimental to synaptic transmission and might characterize the early stages of many neurological diseases. Thus, the characterization of both molecular players and pathway involved in mitochondria dysfunction will provide new chances to identify pharmacological target for new mitochondria-based drugs aimed at interrupting or slowing down pathological processes and/or ameliorating symptoms of neurological disorders. In this review we provide a current view on the role of mitochondria for neuronal function and how mitochondrial functions impinge on neurological diseases.

6.
Cephalalgia ; 31(5): 597-602, 2011 Apr.
Artículo en Inglés | MEDLINE | ID: mdl-21123628

RESUMEN

BACKGROUND: Previous studies have suggested a relationship between 'red ear syndrome' (RES) and pediatric migraine. Aims of this study were (i) to assess the frequency, specificity and sensitivity of RES in a population of pediatric migraineurs and (ii) to establish the pathophysiological mechanisms of RES associated with migraine. METHODS AND RESULTS: A total of 226 children suffering from headache (aged 4-17 years) were enrolled. One hundred and seventy-two (76.4%) were affected by migraine, the remaining 54 (23.6%) by other primary headaches. RES was followed significantly more frequently by migraine (23.3%; p < .0001), and was characterized by high specificity and positive predictive value (96.3 and 95.3%, respectively). According to the univariate statistical analysis, RES showed a statistically significant association with male gender, throbbing quality of the pain, vomiting and phonophobia. It was confirmed by a multivariate stepwise logistic regression model only for the throbbing quality of the pain, vomiting and male gender. CONCLUSIONS: Our study showed that (i) in children, RES is a highly specific sign for migraine. In addition, the evidence of an association of RES with some migraine features partially provoked by the parasympathetic system supports the hypothesis of a shared pathophysiological background (e.g. via the activation of the trigeminal-autonomic reflex).


Asunto(s)
Enfermedades del Oído/epidemiología , Enfermedades del Oído/etiología , Trastornos Migrañosos/complicaciones , Adolescente , Niño , Preescolar , Femenino , Humanos , Masculino , Prevalencia
7.
Eur J Neurol ; 17(3): 391-7, 2010 Mar.
Artículo en Inglés | MEDLINE | ID: mdl-19863646

RESUMEN

BACKGROUND AND PURPOSE: There are few population-based surveys on multiple sclerosis (MS) survival. To investigate MS survival in MS patients recruited during surveys conducted in Sicily. METHODS: Multiple sclerosis patients identified during previous surveys were randomly matched to two referent subjects by residence, year of birth, and gender. Living status was obtained by municipality records (end of follow-up June, 30th 2007) and, for the deceased, date and causes of death were searched. Kaplan-Meier plots were used to calculate differences in mortality between MS patients and referent subjects. MS risks for mortality with 95% confidence intervals (CI) were also calculated. RESULTS: We included 194 MS patients and 388 matched persons. Thirty MS patients (15.5%) and 28 referents (7.2%) had died until the end of follow-up. Mean survival from onset of the disease to death was 20.6 years. Mean age at death was 55.5 for MS patients and 64.8 for the referents. Adjusted Hazard Ratios for mortality in MS was 1.81 (95% CI 1.36-2.40). Kaplan-Meier estimates showed a higher mortality amongst patients compared to referent subjects (P < 0.001). CONCLUSIONS: The present study confirms the higher mortality risk in MS patients with no significant gender difference. Causes of death are related to complications of high disability and to increasing age.


Asunto(s)
Esclerosis Múltiple/mortalidad , Adulto , Factores de Edad , Edad de Inicio , Estudios de Casos y Controles , Causas de Muerte , Estudios de Cohortes , Femenino , Estudios de Seguimiento , Humanos , Estimación de Kaplan-Meier , Masculino , Persona de Mediana Edad , Análisis Multivariante , Modelos de Riesgos Proporcionales , Factores Sexuales , Sicilia/epidemiología , Factores de Tiempo
9.
Neurol Sci ; 30(4): 361-4, 2009 Aug.
Artículo en Inglés | MEDLINE | ID: mdl-19484186

RESUMEN

Blood levels of total homocysteine (tHcy), cysteine (Cys), total and reduced glutathione (tGSH and rGSH), folic acid (FA), and vitamin B12 (B12) change during ischemic stroke as accompaniment of the tissue damage. The relationship between these changes remains scantly investigated. We evaluated the variation of these molecules in the 48 h after acute large artery atherothrombotic stroke (LAAS) and searched for the presence of matched variation of them. The study involved 50 subjects affected by acute LAAS and 49 healthy controls. Plasma levels of tHcy and Cys were significantly higher and serum levels of FA and B12 and plasma levels of rGSH were significantly lower in the patients than in the control group. Acute LAAS was associated with increased Hcy-decreased tGSH and decreased FA/tGSH. Pathways involved in cellular stress and in tissue repair are activated during acute LAAS.


Asunto(s)
Cisteína/sangre , Glutatión/sangre , Homocisteína/sangre , Trombosis Intracraneal/sangre , Accidente Cerebrovascular/sangre , Vitaminas/sangre , Enfermedad Aguda , Anciano , Anciano de 80 o más Años , Isquemia Encefálica/sangre , Isquemia Encefálica/complicaciones , Femenino , Ácido Fólico/sangre , Humanos , Hiperhomocisteinemia/sangre , Trombosis Intracraneal/complicaciones , Masculino , Persona de Mediana Edad , Factores de Riesgo , Accidente Cerebrovascular/etiología , Vitamina B 12/sangre
11.
Eur J Neurol ; 15(2): 123-7, 2008 Feb.
Artículo en Inglés | MEDLINE | ID: mdl-18217882

RESUMEN

This work was undertaken to evaluate studies on mortality caused by multiple sclerosis (MS), to evaluate if useful inferences can be drawn from survival studies that can be applied to clinical practice. A literature search was carried out to find epidemiological studies on MS prognosis, survival, mortality and causes of death relevant to our aim. The World Health Organization (WHO) reports on worldwide cause-specific mortality were also considered. Studies were evaluated according to the duration of the follow-up study, the year of publication and the methodology used. We evaluated MS survival from a methodological point of view and considered if time trends could be drawn from study results. We conclude that mortality is only slightly higher in MS patients when compared with that in the general population. Mortality is higher particularly for older patients and those with longer disease duration.


Asunto(s)
Esclerosis Múltiple/mortalidad , Factores de Edad , Causas de Muerte , Humanos , Esperanza de Vida , Análisis de Supervivencia , Factores de Tiempo
12.
Eur J Neurol ; 15(9): 965-8, 2008 Sep.
Artículo en Inglés | MEDLINE | ID: mdl-18637822

RESUMEN

BACKGROUND AND PURPOSE: Previous studies on the association between Parkinson's disease (PD) and body mass index (BMI) have reported conflicting results. We investigated the relationship between PD and BMI by a case-control study. METHODS: PD patients were randomly matched to healthy individuals by sex and age. BMI distribution in cases has been compared with BMI of controls and odd ratios (ORs) with 95% CI were calculated. RESULTS: We included 318 PD patients and 318 controls. We observed no association between PD and BMI. BMI distribution in cases and controls was similar also when we adjusted for diabetes, hypercholesterolemia and the time elapsed between PD onset and the interview (OR = 0.99; CI = 0.94-1.03; P = 0.51). CONCLUSIONS: These results did not confirm the previously reported association between PD and BMI. Population characteristics and methodological issues may partially account for the differences observed between the present study and the others.


Asunto(s)
Índice de Masa Corporal , Enfermedad de Parkinson/epidemiología , Adulto , Edad de Inicio , Anciano , Anciano de 80 o más Años , Estudios de Casos y Controles , Café , Comorbilidad , Diabetes Mellitus/epidemiología , Femenino , Humanos , Hipercolesterolemia/epidemiología , Hipertrigliceridemia/epidemiología , Masculino , Persona de Mediana Edad , Obesidad/epidemiología , Sobrepeso/epidemiología , Factores de Riesgo , Fumar/epidemiología , Aumento de Peso , Pérdida de Peso
13.
Parkinsonism Relat Disord ; 14(7): 572-5, 2008 Nov.
Artículo en Inglés | MEDLINE | ID: mdl-18325817

RESUMEN

OBJECTIVE: To estimate prevalence of Parkinson's disease (PD) and other types of parkinsonism in the Aeolian Archipelago, Sicily. METHODS: We studied the frequency of PD and other types of parkinsonism in the Aeolian Archipelago (population 13,431). All potential cases were identified from available medical information sources. To ensure the completeness of the case-findings, a screening questionnaire was also mailed to residents aged 40 years and over. Subjects were considered prevalent if they fulfilled the SNES diagnostic criteria for PD, on prevalence day (January 1, 2001). RESULTS: We identified 17 patients with parkinsonism from medical sources, and 4 from mail-survey. Prevalence for all types of parkinsonism was 156.3/100,000 (95% CI 99.4-234.8). Fourteen subjects fulfilled diagnostic criteria for PD giving a crude prevalence of 104.2/100,000 (95% CI 59.4-170.7) and 422.5/100,000 in the population aged 60 years and over. CONCLUSIONS: Prevalence of all types of parkinsonism and PD found in the Aeolian Archipelago is lower than that previously reported in Sicily.


Asunto(s)
Enfermedad de Parkinson/epidemiología , Trastornos Parkinsonianos/clasificación , Trastornos Parkinsonianos/epidemiología , Adulto , Anciano , Anciano de 80 o más Años , Femenino , Encuestas Epidemiológicas , Humanos , Masculino , Persona de Mediana Edad , Índice de Severidad de la Enfermedad , Sicilia/epidemiología
14.
J Neurol ; 253(1): 33-7, 2006 Jan.
Artículo en Inglés | MEDLINE | ID: mdl-16021349

RESUMEN

In a set of a population- based study, long-term survival of 59 prevalent PD patients was compared with that of individuals free of neurological diseases matched 1:2 by sex and age of enrolment. PD individuals, compared with reference subjects, showed a two-fold increased risk of death (OR 2.1; 95 % CI 1.4, 3.1). Among causes of death, pneumonia and cachexia were significantly more frequent among PD patients than among individuals free of neurological diseases. We confirmed in a long-term follow-up study an increased mortality among PD individuals compared with that of the general population.


Asunto(s)
Planificación en Salud Comunitaria , Enfermedad de Parkinson/epidemiología , Enfermedad de Parkinson/mortalidad , Factores de Edad , Anciano , Anciano de 80 o más Años , Estudios de Casos y Controles , Femenino , Humanos , Estudios Longitudinales , Masculino , Persona de Mediana Edad , Enfermedad de Parkinson/complicaciones , Modelos de Riesgos Proporcionales , Estudios Retrospectivos , Riesgo , Factores de Riesgo , Factores Sexuales , Análisis de Supervivencia , Tasa de Supervivencia
15.
J Child Neurol ; 30(2): 182-6, 2015 Feb.
Artículo en Inglés | MEDLINE | ID: mdl-24846900

RESUMEN

The frequency of cranial autonomic symptoms in children affected by primary headaches is uncertain. The aim of our study was to estimate the frequency of symptoms in pediatric headaches and correlate it with main migraine characteristics. A questionnaire investigating the presence of cranial autonomic symptoms was administered to all children with primary headache for 2 years. A total of 230 children with primary headache (105 males, 125 females) were included. Two hundred two children were affected by migraine and 28 (12.2%) by other primary headaches. Cranial autonomic symptoms were significantly complained by migraineurs (55% vs. 17.8%) (P < .001) and by children with higher frequency of migraine attacks (odds ratio = 2.6, confidence interval = 1.4-4.7, P = .001). Our findings show that cranial autonomic symptoms are rather common during pediatric migraine attacks. The association between cranial autonomic symptoms and higher frequency of attacks might suggest the role of the trigeminal-autonomic reflex in migraine pathophysiology.


Asunto(s)
Enfermedades del Sistema Nervioso Autónomo/diagnóstico , Trastornos Migrañosos/diagnóstico , Adolescente , Distribución de Chi-Cuadrado , Niño , Femenino , Humanos , Estudios Longitudinales , Masculino , Encuestas y Cuestionarios
16.
Neurology ; 56(4): 519-25, 2001 Feb 27.
Artículo en Inglés | MEDLINE | ID: mdl-11222798

RESUMEN

OBJECTIVE: To determine incidence of and risk factors for sudden unexpected death in epilepsy (SUDEP). METHODS: Three epilepsy centers enrolled 4,578 patients and prospectively followed these patients for 16,463 patient-years. The cohort was screened for death annually. Deaths were investigated to determine whether SUDEP occurred. Potential risk factors were compared in SUDEP cases and in controls enrolled contemporaneously at the same center. RESULTS: Incidence of SUDEP was 1.21/1,000 patient-years and was higher among women (1.45/1,000) than men (0.98/1,000). SUDEP accounted for 18% of all deaths. Occurrence of tonic-clonic seizures, treatment with more than two anticonvulsant medications, and full-scale IQ less than 70 were independent risk factors for SUDEP. The number of tonic-clonic seizures was a risk factor only in women. The presence of cerebral structural lesions and use of psychotropic drugs at the last visit were not risk factors for SUDEP in this cohort. Subtherapeutic anticonvulsant levels at the last visit were equally common in the two groups. No particular anticonvulsant appeared to be associated with SUDEP. CONCLUSIONS: These results support the idea that tonic-clonic seizures are an important proximate cause of SUDEP. This information creates a risk profile for SUDEP that may help direct preventative efforts.


Asunto(s)
Muerte Súbita/epidemiología , Muerte Súbita/etiología , Epilepsia/complicaciones , Epilepsia/mortalidad , Adolescente , Adulto , Anciano , Anciano de 80 o más Años , Causas de Muerte , Niño , Preescolar , Estudios de Cohortes , Métodos Epidemiológicos , Femenino , Humanos , Incidencia , Lactante , Recién Nacido , Masculino , Persona de Mediana Edad , Estudios Prospectivos , Factores de Riesgo , Factores de Tiempo
17.
Neuropsychologia ; 34(4): 321-6, 1996 Apr.
Artículo en Inglés | MEDLINE | ID: mdl-8657363

RESUMEN

Transient topographical amnesia (TTA) is the temporary inability to find one's way in familiar or unfamiliar surroundings due to the inability to use well known environmental landmarks for route finding. The syndrome has not been described as having any obvious aetiology and has been thought to be caused by a vascular deficit in right hemispheric structures which are crucial for topographic recognition, i.e. parietal association and parahippocampal cortex. The patient described in the present study complained of several critical episodes of TTA and tonic rigidity of the left limbs. Neuropsychological assessment was normal except for a deficit in spatial memory tasks. Magnetic resonance (MR) imaging of the brain showed an angioma at the border of areas 24d and 23 of the right cingulate cortex. Because area 23 is strategically located in a network that links the parietal associative (area 7a) and parahippocampal cortices, and because these cortical areas are involved in topographical orienting processes, we suggest that a transient functional inactivation of the network caused by epileptic discharges spreading from the damaged cingulate cortex towards the parahippocampal and parietal association cortex could account for the spatial disorder. Similar discharges spreading from area 24d towards the primary motor cortex and/or the spinal cord could account for the episodes of tonic rigidity of the left limbs.


Asunto(s)
Amnesia/fisiopatología , Neoplasias Encefálicas/patología , Giro del Cíngulo/patología , Hemangioma/patología , Amnesia/diagnóstico , Neoplasias Encefálicas/diagnóstico , Hemangioma/diagnóstico , Hipocampo/fisiopatología , Humanos , Imagen por Resonancia Magnética , Masculino , Persona de Mediana Edad , Pruebas Neuropsicológicas , Trastornos de la Percepción/diagnóstico , Trastornos de la Percepción/fisiopatología , Percepción Espacial
18.
Brain Res ; 610(2): 242-7, 1993 May 07.
Artículo en Inglés | MEDLINE | ID: mdl-8319086

RESUMEN

The influence of the ventral tegmental area (VTA) (dopaminergic A10 group neurons) on flight behaviour, induced by hypothalamic stimulation, was studied in the cat. Co-stimulation of hypothalamus and VTA (ipsi- or contralateral) induced an increase of the flight latency. Slow-motion analysis of flight behaviour showed that this increase was due to the augmentation of the fixation latency (FL) whereas the upright latency (UL) was not modified. Sulpiride injection (50 mg/kg i.p.) provoked the disappearance of VTA effect without affecting the basal behavioural sequence. The results show that DA A10 group neurons increase the attentive component of the flight reaction, suggesting a possible influence of the DA A10 system on the mechanisms modulating focused attention in the animal.


Asunto(s)
Reacción de Fuga/fisiología , Hipotálamo/fisiología , Tegmento Mesencefálico/fisiología , Anestesia , Animales , Atención/efectos de los fármacos , Gatos , Dopamina/fisiología , Estimulación Eléctrica , Neuronas/fisiología , Sulpirida/farmacología
19.
Cell Death Dis ; 5: e1545, 2014 Nov 27.
Artículo en Inglés | MEDLINE | ID: mdl-25429622

RESUMEN

Mitochondria are key organelles for the maintenance of life and death of the cell, and their morphology is controlled by continual and balanced fission and fusion dynamics. A balance between these events is mandatory for normal mitochondrial and neuronal function, and emerging evidence indicates that mitochondria undergo extensive fission at an early stage during programmed cell death in several neurodegenerative diseases. A pathway for selective degradation of damaged mitochondria by autophagy, known as mitophagy, has been described, and is of particular importance to sustain neuronal viability. In the present work, we analyzed the effect of autophagy stimulation on mitochondrial function and dynamics in a model of remote degeneration after focal cerebellar lesion. We provided evidence that lesion of a cerebellar hemisphere causes mitochondria depolarization in axotomized precerebellar neurons associated with PTEN-induced putative kinase 1 accumulation and Parkin translocation to mitochondria, block of mitochondrial fusion by Mfn1 degradation, increase of calcineurin activity and dynamin-related protein 1 translocation to mitochondria, and consequent mitochondrial fission. Here we suggest that the observed neuroprotective effect of rapamycin is the result of a dual role: (1) stimulation of autophagy leading to damaged mitochondria removal and (2) enhancement of mitochondria fission to allow their elimination by mitophagy. The involvement of mitochondrial dynamics and mitophagy in brain injury, especially in the context of remote degeneration after acute focal brain damage, has not yet been investigated, and these findings may offer new target for therapeutic intervention to improve functional outcomes following acute brain damage.


Asunto(s)
Autofagia , Lesiones Encefálicas/patología , Dinámicas Mitocondriales , Neuronas/metabolismo , Neuronas/patología , Enfermedad Aguda , Animales , Autofagia/efectos de los fármacos , Axotomía , Lesiones Encefálicas/metabolismo , Calcineurina/metabolismo , Cerebelo/cirugía , Dinaminas/metabolismo , Potencial de la Membrana Mitocondrial/efectos de los fármacos , Ratones Endogámicos C57BL , Mitocondrias/efectos de los fármacos , Mitocondrias/metabolismo , Mitocondrias/ultraestructura , Dinámicas Mitocondriales/efectos de los fármacos , Mitofagia/efectos de los fármacos , Modelos Biológicos , Degeneración Nerviosa/patología , Neuronas/efectos de los fármacos , Neuronas/ultraestructura , Sirolimus/farmacología
20.
Cell Death Differ ; 17(7): 1104-14, 2010 Jul.
Artículo en Inglés | MEDLINE | ID: mdl-19960023

RESUMEN

Caspases are a family of cysteinyl aspartate-specific proteases that are highly conserved in multicellular organisms and function as central regulators of apoptosis. A member of this family, caspase-3, has been identified as a key mediator of apoptosis in neuronal cells. Recent studies in snail, fly and rat suggest that caspase-3 also functions as a regulatory molecule in neurogenesis and synaptic activity. In this study, in addition to providing an overview of the mechanism of caspase-3 activation, we review genetic and pharmacological studies of apoptotic and nonapoptotic functions of caspase-3 and discuss the regulatory mechanism of caspase-3 for executing nonapoptotic functions in the central nervous system. Knowledge of biochemical pathway(s) for nonapoptotic activation and modulation of caspase-3 has potential implications for the understanding of synaptic failure in the pathophysiology of neurological disorders. Fine-tuning of caspase-3 lays down a new challenge in identifying pharmacological avenues for treatment of many neurological disorders.


Asunto(s)
Caspasa 3/metabolismo , Neuronas/enzimología , Animales , Apoptosis , Caspasa 3/genética , Caspasa 3/fisiología , Técnicas de Inactivación de Genes , Ratones , Enfermedades del Sistema Nervioso/etiología , Plasticidad Neuronal/fisiología , Neuronas/citología , Ratas , Transducción de Señal
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA